190 related articles for article (PubMed ID: 18490685)
1. The role of clinical uncertainty in treatment decisions for diabetic patients with uncontrolled blood pressure.
Kerr EA; Zikmund-Fisher BJ; Klamerus ML; Subramanian U; Hogan MM; Hofer TP
Ann Intern Med; 2008 May; 148(10):717-27. PubMed ID: 18490685
[TBL] [Abstract][Full Text] [Related]
2. Physician assessments of medication adherence and decisions to intensify medications for patients with uncontrolled blood pressure: still no better than a coin toss.
Meddings J; Kerr EA; Heisler M; Hofer TP
BMC Health Serv Res; 2012 Aug; 12():270. PubMed ID: 22909303
[TBL] [Abstract][Full Text] [Related]
3. Hypertension treatment intensification among stroke survivors with uncontrolled blood pressure.
Roumie CL; Zillich AJ; Bravata DM; Jaynes HA; Myers LJ; Yoder J; Cheng EM
Stroke; 2015 Feb; 46(2):465-70. PubMed ID: 25550374
[TBL] [Abstract][Full Text] [Related]
4. More than a pain in the neck: how discussing chronic pain affects hypertension medication intensification.
Krein SL; Hofer TP; Holleman R; Piette JD; Klamerus ML; Kerr EA
J Gen Intern Med; 2009 Aug; 24(8):911-6. PubMed ID: 19479311
[TBL] [Abstract][Full Text] [Related]
5. Blood pressure levels, risk factors and antihypertensive treatments: lessons from the SHEAF study.
Mallion JM; Genès N; Vaur L; Clerson P; Vaïsse B; Bobrie G; Chatellier G
J Hum Hypertens; 2001 Dec; 15(12):841-8. PubMed ID: 11773986
[TBL] [Abstract][Full Text] [Related]
6. Optimal systolic blood pressure target, time to intensification, and time to follow-up in treatment of hypertension: population based retrospective cohort study.
Xu W; Goldberg SI; Shubina M; Turchin A
BMJ; 2015 Feb; 350():h158. PubMed ID: 25655523
[TBL] [Abstract][Full Text] [Related]
7. Failure to intensify antihypertensive treatment by primary care providers: a cohort study in adults with diabetes mellitus and hypertension.
Bolen SD; Samuels TA; Yeh HC; Marinopoulos SS; McGuire M; Abuid M; Brancati FL
J Gen Intern Med; 2008 May; 23(5):543-50. PubMed ID: 18219539
[TBL] [Abstract][Full Text] [Related]
8. When more is not better: treatment intensification among hypertensive patients with poor medication adherence.
Heisler M; Hogan MM; Hofer TP; Schmittdiel JA; Pladevall M; Kerr EA
Circulation; 2008 Jun; 117(22):2884-92. PubMed ID: 18506011
[TBL] [Abstract][Full Text] [Related]
9. Improving blood pressure control through provider education, provider alerts, and patient education: a cluster randomized trial.
Roumie CL; Elasy TA; Greevy R; Griffin MR; Liu X; Stone WJ; Wallston KA; Dittus RS; Alvarez V; Cobb J; Speroff T
Ann Intern Med; 2006 Aug; 145(3):165-75. PubMed ID: 16880458
[TBL] [Abstract][Full Text] [Related]
10. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Digital Medicines to Improve Clinical Outcomes in Patients with Uncontrolled Hypertension and Type 2 Diabetes: Prospective, Open-Label, Cluster-Randomized Pilot Clinical Trial.
Frias J; Virdi N; Raja P; Kim Y; Savage G; Osterberg L
J Med Internet Res; 2017 Jul; 19(7):e246. PubMed ID: 28698169
[TBL] [Abstract][Full Text] [Related]
12. An Electronic Adherence Measurement Intervention to Reduce Clinical Inertia in the Treatment of Uncontrolled Hypertension: The MATCH Cluster Randomized Clinical Trial.
Kronish IM; Moise N; McGinn T; Quan Y; Chaplin W; Gallagher BD; Davidson KW
J Gen Intern Med; 2016 Nov; 31(11):1294-1300. PubMed ID: 27255750
[TBL] [Abstract][Full Text] [Related]
13. Treatment decisions for complex patients: differences between primary care physicians and midlevel providers.
Subramanian U; Kerr EA; Klamerus ML; Zikmund-Fisher BJ; Holleman RG; Hofer TP
Am J Manag Care; 2009 Jun; 15(6):373-80. PubMed ID: 19514803
[TBL] [Abstract][Full Text] [Related]
14. Patient-provider concordance in the prioritization of health conditions among hypertensive diabetes patients.
Zulman DM; Kerr EA; Hofer TP; Heisler M; Zikmund-Fisher BJ
J Gen Intern Med; 2010 May; 25(5):408-14. PubMed ID: 20127197
[TBL] [Abstract][Full Text] [Related]
15. Impact of a system-wide quality improvement initiative on blood pressure control: a cohort analysis.
Pfoh ER; Martinez K; Vakharia N; Rothberg M
BMJ Qual Saf; 2020 Mar; 29(3):225-231. PubMed ID: 31473665
[TBL] [Abstract][Full Text] [Related]
16. [Effect of a fixed-dose combination of perindopril arginine/amlodipine on the level and variability of blood pressure according to its office visit-to-visit measurements and self-measurements at home: A subanalysis of the PREVOSHODSTVO (SUPERIORITY) program].
Ostroumova OD
Ter Arkh; 2017; 89(8):29-36. PubMed ID: 28914848
[TBL] [Abstract][Full Text] [Related]
17. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
18. Adding a New Medication Versus Maximizing Dose to Intensify Hypertension Treatment in Older Adults : A Retrospective Observational Study.
Aubert CE; Sussman JB; Hofer TP; Cushman WC; Ha JK; Min L
Ann Intern Med; 2021 Dec; 174(12):1666-1673. PubMed ID: 34606315
[TBL] [Abstract][Full Text] [Related]
19. A multimodal blood pressure control intervention in 3 healthcare systems.
Magid DJ; Ho PM; Olson KL; Brand DW; Welch LK; Snow KE; Lambert-Kerzner AC; Plomondon ME; Havranek EP
Am J Manag Care; 2011 Apr; 17(4):e96-103. PubMed ID: 21774100
[TBL] [Abstract][Full Text] [Related]
20. Impact of Empagliflozin on Blood Pressure in Patients With Type 2 Diabetes Mellitus and Hypertension by Background Antihypertensive Medication.
Mancia G; Cannon CP; Tikkanen I; Zeller C; Ley L; Woerle HJ; Broedl UC; Johansen OE
Hypertension; 2016 Dec; 68(6):1355-1364. PubMed ID: 27977392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
